West Pharmaceutical Services, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from West Pharmaceutical Services, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 33.3 times by its yearly operating cash. Higher than 93% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$138Over the last 3 years, every $100 of reported profit came with $138 of operating cash.
Lower than 58% of Healthcare companies in United States.
Self-Funding Ratio
2.1×Over the last 3 years its own operating cash covered its investment spending (capex) 2.1 times.
Higher than 75% of Healthcare companies in United States.
Cash Locked Ratio
$23For every $100 of sales, $23 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $22 tied up three years earlier.
Less money tied up than 52% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$49Sales grew 6% in 3 years, but profit fell: $49 less profit per $100 of extra sales.
Lower than 82% of Healthcare companies in United States.
Asset Productivity Ratio
+6% / +18%In 3 years sales changed by +6% while total assets changed by +18%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
33.3×Debt due within a year is covered 33.3 times by its yearly operating cash.
Higher than 93% of Healthcare companies in United States.
Cash Cushion Ratio
+2%Cash, after subtracting all debt, equals 2% of its market value (net cash).
Lower than 64% of Healthcare companies in United States.
Tangible Assets Ratio
97%Of every $100 the company owns, $97 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 81% of Healthcare companies in United States.
Tangible Net Worth Ratio
96%Of every $100 of net worth, $96 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 83% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
West Pharmaceutical Services, Inc. owes $0.27 for every $1 it owns. Net profit rose 0% in the year to Dec 2025, and shrank 6% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
50.5Investors pay $50.5 for every $1 of West Pharmaceutical Services, Inc.'s yearly profit, higher than 81% of Healthcare companies in United States.
P/B ratio
9.27The share price is 9.27 times West Pharmaceutical Services, Inc.'s book value per share, higher than 85% of Healthcare companies in United States.
Market cap
$27.7 BThe total market value of all of West Pharmaceutical Services, Inc.'s shares at today's price (share price × number of shares), larger than 95% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$3.0 BWhat West Pharmaceutical Services, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$42.49Net worth divided by the number of shares. The share price of $394.03 is 9.3 times this, which is the P/B above.
Return on equity (ROE)
19.1%West Pharmaceutical Services, Inc. earned 19.1% on its shareholders' money over the last year, higher than 89% of Healthcare companies in United States.
Owes vs Owns
0.27×West Pharmaceutical Services, Inc. owes $0.27 for every $1 it owns (low), lower than 64% of Healthcare companies in United States.
Dividend yield
0.26%West Pharmaceutical Services, Inc. pays 0.26% of its share price as dividends a year, lower than 92% of dividend-paying Healthcare companies in United States.
Revenue growth
+6%Revenue rose 6% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Profit growth
+0%Net profit rose 0% in the year to Dec 2025, and shrank 6% a year on average over 3 years.
Profit margin
16.1%West Pharmaceutical Services, Inc. keeps $16 of every $100 of revenue as net profit.
Cash quality
1.5×Cash from West Pharmaceutical Services, Inc.'s business was 1.5× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
1272.2×West Pharmaceutical Services, Inc.'s operating profit covered its interest costs 1272.2 times in the year to Dec 2025.
Cash vs debt
Net cashWest Pharmaceutical Services, Inc. held $470 M more cash than debt (net cash) at Dec 2025.
Questions
What is West Pharmaceutical Services, Inc.'s P/E ratio?
Investors pay $50.5 for every $1 of West Pharmaceutical Services, Inc.'s yearly profit, higher than 81% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For West Pharmaceutical Services, Inc.: $27.7 B ÷ $3.0 B (30 Jun 2026) = 9.3.
What is West Pharmaceutical Services, Inc.'s return on equity?
West Pharmaceutical Services, Inc. earned 19.1% on its shareholders' money over the last year, higher than 89% of Healthcare companies in United States.
How much does West Pharmaceutical Services, Inc. owe compared with what it owns?
West Pharmaceutical Services, Inc. owes $0.27 for every $1 it owns (low), lower than 64% of Healthcare companies in United States.
Does West Pharmaceutical Services, Inc. pay a dividend?
Yes. West Pharmaceutical Services, Inc. pays 0.26% of its share price as dividends a year, lower than 92% of dividend-paying Healthcare companies in United States.
Is West Pharmaceutical Services, Inc.'s revenue growing?
Revenue rose 6% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.